|
|
Volumn 133, Issue 3, 2014, Pages
|
|
An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualized
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
AZATHIOPRINE;
CYCLOSPORIN;
DESLORATADINE;
FEXOFENADINE;
IMMUNOGLOBULIN E;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OMALIZUMAB;
PREDNISOLONE;
ADOLESCENT;
ADULT;
AGED;
ALGORITHM;
ALLERGIC DISEASE;
ALLERGIC RHINITIS;
ANAPHYLAXIS;
AUTOIMMUNE DISEASE;
CHILD;
CHRONIC URTICARIA;
CLINICAL ARTICLE;
CONTACT URTICARIA;
DERMOGRAPHISM;
DIABETES MELLITUS;
DRUG DOSE INCREASE;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
DRUG TREATMENT FAILURE;
FEMALE;
HUMAN;
HYPOTHYROIDISM;
LETTER;
MALE;
MIDDLE AGED;
OPTIMAL DRUG DOSE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
SCHOOL CHILD;
ULTRAVIOLET B RADIATION;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
ALGORITHMS;
ANTI-ALLERGIC AGENTS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHILD;
CHRONIC DISEASE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
TIME FACTORS;
URTICARIA;
|
|
EID: 84896709323
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2013.10.015 Document Type: Article |
|
Times cited : (53)
|
|
References (9)
|
